Bisphenol S Promotes the Cell Cycle Progression and Cell Proliferation Through ER Alpha-Cyclin D-CDK4/6-pRb Pathway in MCF-7 Breast Cancer Cells

Zhenxian Lin,Xiaona Zhang,Fei Zhao,Shaoguo Ru

DOI: https://doi.org/10.1016/j.taap.2019.01.017

IF: 4.46

2019-01-01

Toxicology and Applied Pharmacology

Abstract:Bisphenol S (BPS), exhibiting estrogenic activity, has been reported to promote cell proliferation in MCF-7 breast cancer cells; however, the underlying mechanism remains unclear. In this study, BPS (1-100 mu M) significantly promoted cell proliferation in ERa positive MCF-7 cells, but not in ERa negative MDA-MB-231 or SK-BR-3 cells, confirming the important role of ERa in BPS-induced cell proliferation. Results of the flow cytometry analysis indicated that 10 mu M BPS promoted MCF-7 proliferation by accelerating G 1 to S phase transition of the cell cycle. BPS increased cyclin D1 expression and phospho-retinoblastoma (p-Rb) levels, resulting in the release of E2F transcription factors and the increased expression of downstream cyclin E2 and cyclin A2 genes to promote the cell cycle progression. Moreover, BPS-induced Rb phosphorylation and cell cycle progression were prevented by the ERa inhibitor ICI 182,780 and methylpiperidino pyrazole, as well as cyclin-dependent kinase 4 (CDK4) and CDK6 inhibitor PD 0332991, indicating that the underlying mechanisms involve ER alpha-dependent pathways but also mediated by cyclin D-CDK4/6. Overall, our result showed, for the first time, that BPS promoted cell cycle progression and cell proliferation through the ER alpha-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells. This study provides a novel insight regarding the potential role of cyclin D-CDK4/6-pRb pathway in mediating the proliferative effects of BPS in breast cancer cells.